Advertent Biotherapeutics, Inc.
East Lansing, MI
- UEI
- JYQ5STUGHCA9
- CAGE
- 89GM7
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 4942 Dawn Ave #129, East Lansing, MI 48823, USA
- Website
- advertentbio.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A novel agent for preventing fatty degeneration of muscles in LGMD2B - abstract muscular dystrophies are grave genetic… | National Insititue of Arthritis and Musculoskeletal and Skin Diseases | $2,043,068 | |
| A novel agent for preventing fatty degeneration of muscles in LGMD2B - abstract muscular dystrophies are grave genetic… | National Insititue of Arthritis and Musculoskeletal and Skin Diseases | $500,022 |
Quick answers
What is Advertent Biotherapeutics, Inc.'s UEI?
Advertent Biotherapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is JYQ5STUGHCA9.
What is Advertent Biotherapeutics, Inc.'s CAGE code?
Advertent Biotherapeutics, Inc.'s CAGE code is 89GM7.
What is Advertent Biotherapeutics, Inc.'s primary NAICS code?
Advertent Biotherapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Advertent Biotherapeutics, Inc. located?
Advertent Biotherapeutics, Inc.'s physical address in SAM.gov is 4942 Dawn Ave #129, East Lansing, MI 48823, USA.
Is Advertent Biotherapeutics, Inc. registered in SAM.gov?
Yes. Advertent Biotherapeutics, Inc.'s SAM.gov registration is active through December 2, 2026.
What is Advertent Biotherapeutics, Inc.'s most recent federal award?
Advertent Biotherapeutics, Inc.'s most recent federal grant award is A novel agent for preventing fatty degeneration of muscles in LGMD2B - abstract muscular dystrophies are grave genetic… (R44AR081168), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases, on July 1, 2025.
On GovTribe
See Advertent Biotherapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors